Jointown Pharmaceutical Group Co., Ltd (SHA:600998)
5.23
-0.01 (-0.19%)
May 14, 2025, 2:45 PM CST
SHA:600998 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 26,129 | 25,148 | 26,691 | 24,052 | 26,919 | 33,241 | Upgrade
|
Market Cap Growth | -19.34% | -5.78% | 10.97% | -10.65% | -19.02% | 27.82% | Upgrade
|
Enterprise Value | 33,426 | 31,376 | 33,203 | 31,612 | 39,715 | 45,758 | Upgrade
|
Last Close Price | 5.24 | 5.12 | 5.25 | 4.52 | 4.98 | 5.95 | Upgrade
|
PE Ratio | 9.04 | 10.03 | 12.28 | 11.54 | 11.00 | 10.81 | Upgrade
|
Forward PE | 12.39 | 12.69 | 10.60 | 9.52 | 10.44 | 15.14 | Upgrade
|
PS Ratio | 0.17 | 0.17 | 0.18 | 0.17 | 0.22 | 0.30 | Upgrade
|
PB Ratio | 0.75 | 0.75 | 0.91 | 0.84 | 0.99 | 1.30 | Upgrade
|
P/TBV Ratio | 1.12 | 1.03 | 1.25 | 1.20 | 1.44 | 1.95 | Upgrade
|
P/FCF Ratio | 11.77 | 11.94 | 7.22 | 8.77 | 12.99 | 16.73 | Upgrade
|
P/OCF Ratio | 7.67 | 8.16 | 5.62 | 6.03 | 7.78 | 9.65 | Upgrade
|
PEG Ratio | - | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | Upgrade
|
EV/Sales Ratio | 0.22 | 0.21 | 0.22 | 0.23 | 0.32 | 0.41 | Upgrade
|
EV/EBITDA Ratio | 7.10 | 6.80 | 7.02 | 7.16 | 10.93 | 10.80 | Upgrade
|
EV/EBIT Ratio | 8.57 | 8.00 | 8.19 | 8.34 | 12.86 | 12.29 | Upgrade
|
EV/FCF Ratio | 15.05 | 14.89 | 8.98 | 11.53 | 19.16 | 23.03 | Upgrade
|
Debt / Equity Ratio | 0.46 | 0.39 | 0.50 | 0.53 | 0.65 | 0.68 | Upgrade
|
Debt / EBITDA Ratio | 3.43 | 2.79 | 3.05 | 3.35 | 4.67 | 4.14 | Upgrade
|
Debt / FCF Ratio | 7.27 | 6.27 | 3.99 | 5.53 | 8.43 | 8.82 | Upgrade
|
Asset Turnover | 1.49 | 1.56 | 1.62 | 1.58 | 1.47 | 1.46 | Upgrade
|
Inventory Turnover | 6.99 | 6.52 | 7.40 | 7.92 | 7.44 | 7.00 | Upgrade
|
Quick Ratio | 0.87 | 0.82 | 0.83 | 0.85 | 0.90 | 0.92 | Upgrade
|
Current Ratio | 1.26 | 1.27 | 1.26 | 1.27 | 1.29 | 1.29 | Upgrade
|
Return on Equity (ROE) | 9.93% | 8.84% | 7.87% | 8.20% | 9.90% | 14.23% | Upgrade
|
Return on Assets (ROA) | 2.37% | 2.51% | 2.74% | 2.66% | 2.31% | 3.06% | Upgrade
|
Return on Capital (ROIC) | 4.98% | 5.39% | 5.75% | 5.36% | 4.40% | 5.85% | Upgrade
|
Return on Capital Employed (ROCE) | 10.40% | 10.90% | 12.40% | 11.60% | 10.10% | 12.60% | Upgrade
|
Earnings Yield | 11.25% | 9.97% | 8.14% | 8.67% | 9.10% | 9.25% | Upgrade
|
FCF Yield | 8.50% | 8.38% | 13.86% | 11.40% | 7.70% | 5.98% | Upgrade
|
Dividend Yield | 3.83% | 3.91% | 3.69% | 4.11% | 2.24% | 3.12% | Upgrade
|
Payout Ratio | 48.22% | 61.96% | 75.20% | 66.58% | 68.69% | 23.99% | Upgrade
|
Buyback Yield / Dilution | -1.69% | 0.81% | 4.14% | -1.68% | 2.84% | 3.46% | Upgrade
|
Total Shareholder Return | 2.15% | 4.72% | 7.83% | 2.42% | 5.08% | 6.59% | Upgrade
|
Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.